Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts → 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (From TradingTips) (Ad) Free ELEV Stock Alerts $3.48 -0.05 (-1.42%) (As of 02:30 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 2) -$0.23 Missed By -$0.02 Consensus EPS (May. 2) -$0.21 Get Elevation Oncology Earnings AlertsEnter your email address below to receive the latest news and earnings results for ELEV and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueELEV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ELEV Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressOptions expert shares his top option strategy for freeA 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.Check it out, simply follow this link here. Elevation Oncology Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.23)($0.19)($0.21)Q2 20243($0.26)($0.20)($0.22)Q3 20243($0.22)($0.21)($0.21)Q4 20243($0.23)($0.22)($0.23)FY 202412($0.94)($0.82)($0.87)Q1 20252($0.23)($0.15)($0.19)Q2 20252($0.23)($0.14)($0.19)Q3 20252($0.24)($0.16)($0.20)Q4 20252($0.16)($0.16)($0.16)FY 20258($0.86)($0.61)($0.74)ELEV Earnings Date and InformationElevation Oncology last posted its quarterly earnings data on May 2nd, 2024. The reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.02. Elevation Oncology has generated ($1.04) earnings per share over the last year (($1.04) diluted earnings per share). Earnings for Elevation Oncology are expected to decrease in the coming year, from ($0.92) to ($0.95) per share. Elevation Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Elevation Oncology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/2/2024Q1 2024($0.21)($0.23)($0.02)($0.23)--3/6/2024Q4 2023($0.21)($0.19)+$0.02($0.19)--11/2/2023Q3 2023($0.34)($0.25)+$0.09($0.25)--8/3/2023Q2 2023($0.28)($0.37)($0.09)($0.37)--5/15/2023Q1 2023($0.51)($0.50)+$0.01($0.28)--3/9/2023Q4 2022($0.67)($4.09)($3.42)($4.09)-- Get the Latest News and Ratings for ELEV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/3/2022Q3 2022($1.12)($1.67)($0.55)($1.67)--8/4/2022Q2 2022($0.80)($0.86)($0.06)($0.86)--5/5/2022Q1 2022($0.51)($0.74)($0.23)($0.74)--3/3/2022Q4 2021($0.59)($0.41)+$0.18($0.41)--11/11/2021Q3 2021($0.38)($0.53)($0.15)($0.53)--8/12/2021Q2 2021($0.38)($4.84)($4.46)($4.84)-- Elevation Oncology Earnings - Frequently Asked Questions When is Elevation Oncology's earnings date? Elevation Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ELEV's earnings history. Did Elevation Oncology beat their earnings estimates last quarter? In the previous quarter, Elevation Oncology (NASDAQ:ELEV) missed the analysts' consensus estimate of ($0.21) by $0.02 with a reported earnings per share (EPS) of ($0.23). Learn more on analysts' earnings estimate vs. ELEV's actual earnings. How much profit does Elevation Oncology generate each year? Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$45.70 million. ELEV has generated -$1.04 earnings per share over the last four quarters. What is Elevation Oncology's EPS forecast for next year? Elevation Oncology's earnings are expected to decrease from ($0.92) per share to ($0.95) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RAIN Earnings INKT Earnings BOLT Earnings INBX Earnings RLAY Earnings MESO Earnings PROK Earnings PRME Earnings SRRK Earnings CRGX Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:ELEV) was last updated on 6/10/2024 by MarketBeat.com Staff From Our Partners[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.